Biotech

All Articles

AbbVie Parkinson's medication from $8.7 B Cerevel buyout scores

.On the exact same day that some Parkinson's disease drugs are actually being questioned, AbbVie has...

Arch closes $3B-plus fund to nurture biopharma upstarts

.On the heels of a $3 billion fund coming from Bain Resources Life Sciences, Arc Venture Partners is...

Orion to use Aitia's 'digital identical twins' to discover brand-new cancer medications

.Finnish biotech Orion has actually spied possible in Aitia's "digital twin" technology to cultivate...

Windtree's shock med increases blood pressure in newest phase 2 gain

.While Windtree Therapies has struggled to increase the financial origins needed to have to endure, ...

2 cancer cells biotechs merge, creating global impact

.OncoC4 is actually taking AcroImmune-- as well as its in-house professional production capabilities...

Amgen documents very first period 3 gain for $400M chronic eczema medication

.Amgen has actually shared (PDF) the 1st period 3 records on its own $400 million chronic eczema med...

Biogen, UCB record stage 3 lupus win after neglecting earlier test

.Biogen and also UCB's gamble on advancing in to phase 3 astride an unsuccessful research study want...

Aptadir wishes brand new RNA preventions may reverse tricky cancers

.Italian biotech Aptadir Therapeutics has introduced along with the guarantee that its own pipe of p...

Wave surfs DMD success to regulatory authorities' doors, sending stockpile

.Surge Life Sciences has actually met its own goal in a Duchenne muscle dystrophy (DMD) research stu...

Sanofi plucks brand-new CSO coming from in-stealth biotech

.After a couple of years in biotech, Mike Quigley, Ph.D., is coming back to the pharma layer, occupy...